The effect of the oral PKC β inhibitor ruboxistaurin on vision loss in two phase 3 studies

Matthew J Sheetz, Lloyd Paul Aiello, Matthew D Davis, Ronald Danis, Toke Bek, Jose Cunha-Vaz, Nazila Shahri, Paul H Berg, MBDL and MBCU Study Groups

57 Citationer (Scopus)

Abstract

To assess the effect of ruboxistaurin (RBX) on vision loss through a prospectively defined combined analysis of two phase 3 trials (MBDL and MBCU).
OriginalsprogEngelsk
TidsskriftInvestigative ophthalmology & visual science
Vol/bind54
Udgave nummer3
Sider (fra-til)1750-7
Antal sider8
ISSN0146-0404
DOI
StatusUdgivet - mar. 2013

Fingeraftryk

Dyk ned i forskningsemnerne om 'The effect of the oral PKC β inhibitor ruboxistaurin on vision loss in two phase 3 studies'. Sammen danner de et unikt fingeraftryk.

Citationsformater